Pfizer, Avant Ink R&D Deal for Cancer Vaccine
The Big Pharma will assume all development costs for CDX-110 and pay royalties to the biotech on the sales if the drug's approved. 7 months ago
TheStreet Click here to Read the Full StoryThe Big Pharma will assume all development costs for CDX-110 and pay royalties to the biotech on the sales if the drug's approved. 7 months ago
TheStreet Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook